Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10)
NCT ID: NCT00004306
Last Updated: 2012-03-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
18 participants
OBSERVATIONAL
1999-11-30
2009-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
II. Perform detailed clinical evaluations on patients with recessively inherited ataxias.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias
NCT01060371
The Study of Transcranial Magnetic Stimulation in the Regulation of Spinocerebellar Ataxia
NCT06904716
Measuring Neurological Impairment and Functional Visual Assessment In Spinocerebellar Ataxias
NCT00654251
Functional and Structural Imaging and Motor Control in Spinocerebellar Ataxia
NCT02488031
A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
NCT06585605
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A neuropathologic evaluation is conducted postmortem, when possible.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
3 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Texas Medical Branch, Galveston
OTHER
Office of Rare Diseases (ORD)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tetsuo Ashizawa
Professor and Chair, Department of Neurology, The University of Texas Medical Branch
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tetsuo Ashizawa, MD
Role: PRINCIPAL_INVESTIGATOR
University of Texas, Galveston
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Texas Medical Branch at Galveston
Galveston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
199/11796
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.